Argenx Se (ARGX) Tax Rate (2017 - 2026)
Argenx Se's (ARGX) quarterly Tax Rate came in at 10.91% in Q2 2026, down 2639.0% YoY from 0.43% in Q2 2025, and down 20.39% on a QoQ basis from 13.7% in Q1 2026.
Analysis
Argenx Se (ARGX) Tax Rate (2017 - 2026) Analysis & Trends
Argenx Se (ARGX) has 8 years of Tax Rate data on file, last reported at 10.91% in Q2 2026.
- Quarterly Tax Rate fell 2639.0% year-over-year to 10.91% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 10.91% (up 140.0% YoY) and the FY2025 annual result came in at 1.05%, up 87693.0% from the prior year.
- Tax Rate fell to 10.91% in Q2 2026, from 13.7% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 37.3% in Q2 2025 to a low of 16.31% in Q1 2025.
- A 3-year average of 8.51% and a median of 11.26% in 2022 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 6298 bps in 2022, down 4435 bps in 2022.
- Tracing ARGX's Tax Rate over 3 years: stood at 11.61% in 2022, then jumped by 221 bps to 37.3% in 2025, then sank by 71 bps to 10.91% in 2026.
- The last three Tax Rate figures came in at 10.91% (Q2 2026), 13.7% (Q1 2026), and 37.3% (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 22.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.89% |
| Mar 31, 2026 | -13.67% |
| Dec 31, 2025 | 32.15% |
| Sep 30, 2025 | -10.83% |
| Jun 30, 2025 | -14.48% |
| Mar 31, 2025 | -16.31% |
| Dec 31, 2024 | 820.09% |
| Sep 30, 2024 | 3.85% |
| Jun 30, 2024 | -293.73% |
| Mar 31, 2024 | -17.15% |
| Dec 31, 2023 | 62.10% |
| Sep 30, 2023 | -12.77% |
| Jun 30, 2023 | 12.53% |
| Mar 31, 2023 | -62.10% |
| Dec 31, 2022 | -6.37% |
| Sep 30, 2022 | -2.48% |
| Jun 30, 2022 | -3.79% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | -2.88% |
| Sep 30, 2021 | 1.19% |